CymitQuimica logo

Lorlatinib acetate

CAS:

Ref. 3D-ZBD20718

1mg
Discontinued
5mg
Discontinued
10mg
Discontinued
25mg
Discontinued
50mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

Lorlatinib acetate
Biosynth

Product Information

Name:Lorlatinib acetate
Controlled Product
Brand:Biosynth
Description:Lorlatinib acetate is a small-molecule tyrosine kinase inhibitor, which is a synthetic pharmaceutical compound designed to specifically inhibit the activity of anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (ROS1). This compound is derived through complex chemical synthesis to ensure specificity and potency in its mechanism of action. Lorlatinib acetate functions by selectively binding to the ATP-binding site of ALK and ROS1, leading to the inhibition of downstream signaling pathways that promote tumor cell proliferation and survival. This targeted action results in the interruption of cancer cell growth and the induction of apoptosis in cancer cells harboring ALK and ROS1 aberrations.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:466.5 g/mol
Formula:C23H23FN6O4
Purity:Min. 95%

Inquiry about discontinued product: Lorlatinib acetate

◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.